SIVEXTRO J Code: J3090
Injection, tedizolid phosphate, 1 mg
Q4 2026 Medicare Payment Limit for J3090, effective October 1, 2026: $2.062 per HCPCS billing unit, down 0.9% from $2.081. From CMS's final file.
Drug & Product Overview
About SIVEXTRO
Sivextro is a medication aligned to the HCPCS J Code: J3090 for billing, pricing, and reimbursement purposes in the United States. This Antibiotic medication is administered via the intravenous route and manufactured by Merck Sharp & Dohme Corp.
According to CMS Drug Use Information: This medication is used to treat or prevent serious bacterial infections of the skin. It works by stopping the growth of bacteria.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 67919-0040-02 | Sivextro | Merck Sharp & Dohme LLC | 2000 | 200 MG / 4 ML |
| •••••-••••-•• Log in to view | SIVEXTRO | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
SIVEXTRO Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →SIVEXTRO CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) |
CMS does not include Sivextro (J3090) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J3090. Wastage billing guide →
SIVEXTRO Medically Unlikely Edits (MUE)
The most billing units of J3090 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
SIVEXTRO Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Sivextro billing and coding guide?
Are there any available Sivextro patient assistance programs?
Where can I find Sivextro prescribing information?
Where can I find Sivextro side effect information?
Does billing SIVEXTRO require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to SIVEXTRO.